[Home](https://github.com/mm80843/T3.5/blob/pages/index.md) >> Class: [Benef](https://github.com/mm80843/T3.5/tree/pages/docs/Benef/index.md) >> Individual ID:PBN__Benef_833 

# __Cost savings__

## Articles mentionning this Benefit

* [Computational analysis of SARS-CoV-2/COVID-19 surveillance by wastewater-based epidemiology locally and globally: Feasibility, economy, opportunities and challenges](https://github.com/mm80843/T3.5/blob/pages/Article/PBN__Article_252.md)
* [The Impact of Pandemic Crisis on the Survival of Construction Industry: A Case of COVID-19](https://github.com/mm80843/T3.5/blob/pages/Article/PBN__Article_168.md)

## Category to which it belongs

* [Enhanced valuation and risk assessment for properties and individuals, leading to overall value and security improvement.](https://github.com/mm80843/T3.5/blob/pages/PBNCategory/PBN__PBNCategory_46.md)

## Description of actual returns pertaining to this benefit

* [Investing in the combination of wbe and clinical testing would result in significant cost savings for governments and healthcare systems.](https://github.com/mm80843/T3.5/blob/pages/BenefReturn/PBN__BenefReturn_908.md)
* [Private investors would benefit from reduced labor costs, leading to higher profitability.](https://github.com/mm80843/T3.5/blob/pages/BenefReturn/PBN__BenefReturn_1354.md)

## Name of the Benefit

Workforce reduction can lead to cost savings in terms of labor expenses.

## Risks which can benefit from this action

* [Combined use of wbe followed by clinical testing](https://github.com/mm80843/T3.5/blob/pages/Mitigation/PBN__Mitigation_833.md)
* [Workforce reduction](https://github.com/mm80843/T3.5/blob/pages/Mitigation/PBN__Mitigation_1204.md)

## Stakeholders benefitting from this Benefit

* [Construction companies](https://github.com/mm80843/T3.5/blob/pages/Stakeholder/PBN__Stakeholder_73.md)
* [Government](https://github.com/mm80843/T3.5/blob/pages/Stakeholder/PBN__Stakeholder_181.md)
* [Healthcare systems](https://github.com/mm80843/T3.5/blob/pages/Stakeholder/PBN__Stakeholder_193.md)

